Senior Manager, Economic Modeling
Otsuka Pharmaceutical Companies (U.S.)
Summary
Otsuka is seeking a Senior Manager, Economic Modeling to join the Data Science and AI (DSAI) within the larger Data and Analytics department. This role will provide technical execution and analytical support in health economic modeling and health technology assessment (HTA) across therapeutic areas including neurosciences, nephrology, oncology, and rare disease. The position will support the design, development, quality assurance, and submission of cost-effectiveness analyses, budget impact models, and other health economic evidence for global payer and HTA bodies. This role will work collaboratively with clinical development, medical affairs, market access, regulatory, and commercial teams in executing health economic evidence plans. The role includes vendor management, technical model development and validation, data analysis, HTA submission support, and knowledge-sharing with colleagues and affiliate teams.
Job description
Key Responsibilities
Health Economic Model Development and Quality Assurance
- Design and develop transparent, user-friendly health economic models (cost-effectiveness analyses, budget impact models) using Excel, R, VBA, and specialized software (HeRO3, etc.) under technical direction from the Director, Health Economics.
- Execute sophisticated quality control reviews of externally developed models, including sensitivity analysis, assumption testing, and methodological validation.
- Apply appropriate simulation methodologies (discrete event simulation, Markov models, survival-partition approaches) to model specifications.
- Ensure consistency and rigor in technical approach across multiple therapeutic areas and product programs.
Clinical and Real-world Data Analysis
- Understand and use clinical trial data and real-world data in support of health economic models, including survival analysis, quality-of-life assessment, and health state utility derivation.
- Extract, validate, and integrate efficacy, safety, and clinical outcomes data for model population.
- Support the Director in assessing clinical data quality and appropriateness for health economic applications.
- Contribute to analyses supporting real-world evidence generation and population analysis.
HTA Submission and Evidence Support
- Prepare technical documentation, health economic analysis reports, and model user guides aligned with HTA body requirements (NICE, EMA, CADTH, SMC, and regional bodies).
- Respond to payer and regulatory questions on model methodology, assumptions, and analyses.
- Support the Director in developing country-specific model versions and evidence dossier components.
- Ensure submitted materials meet scientific standards and regulatory expectations.
Technical Training and Knowledge-Sharing
- Provide technical training and model-related support to Otsuka affiliate teams on health economic model use, interpretation, and methodology.
- Document and maintain standard operating procedures, technical specifications, and model documentation.
- Contribute to internal knowledge-sharing on health economic methodologies and HTA best practices.
- Support colleagues in understanding health economic evidence and payer requirements.
Monitoring and Analytical Support
- Monitor external scientific publications and HTA payer guidance relevant to assigned programs.
- Conduct comparative analyses and respond to competitive health economic publications or HTA decisions.
- Support the Director in tracking health economic trends and implications for evidence strategy.
- Maintain awareness of emerging methodologies (Bayesian approaches, real-world comparators, etc.) and their applications.
Requirements
- MS or PhD in Health Economics, Outcomes Research, Epidemiology, Health Services Research, Health Policy, Pharmaceutical Administration, Statistics, or related field
- Minimum 4 to 6 years of pharmaceutical industry or payer experience in health economics, outcomes research, health technology assessment, or related area (MS); or 3 to 5 years (PhD)
- Demonstrated expertise in designing and developing health economic models for HTA reimbursement submissions (e.g., NICE, SMC, EMA, CADTH)
- Strong proficiency in modeling and statistical software, including Excel (advanced: VBA, complex formulas), R, and familiarity with specialized health economic tools (HeRO3, TreeAge)
- Proven ability to analyze and interpret clinical trial data and real-world data, including survival analysis, meta-analysis, and quality-of-life assessment
- Strong written and verbal communication skills
- Ability to explain health economic and statistical concepts to both technical and non-technical audiences
- Demonstrated ability to work effectively in cross-functional teams, manage vendor relationships, and meet deadlines in a dynamic environment
Benefits
- Medical, Dental & Vision
- Prescription Drug Coverage
- Life Insurance
- AD&D Insurance
- Short & Long-Term Disability
- Tuition Reimbursement
- Student Loan Assistance
- 401(k) Matching
- Flexible Time Off
- Paid Holidays
- Paid Leave Programs
Company overview
Otsuka Pharmaceutical Companies (U.S.) represents the American operations of the global Otsuka pharmaceutical group, comprising two main entities: Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). OAPI focuses on commercializing Otsuka-discovered and in-licensed pharmaceutical products in North America, while OPDC handles clinical development and global registration of innovative healthcare products. Headquartered in Princeton, New Jersey, with additional facilities in Rockville, Maryland and Hayward, California, the company employs 1,001-5,000 professionals dedicated to advancing treatments in neuroscience and nephrology. Otsuka has established a strong legacy in the U.S. market since establishing its first research base in 1985, with notable achievements including the development and commercialization of blockbuster medications such as ABILIFY (aripiprazole) for psychiatric disorders and JYNARQUE (tolvaptan) for polycystic kidney disease. The company maintains a robust pipeline focused on central nervous system disorders, nephrology, immunology, and metabolic diseases, driven by its mission of 'creating new products for better health worldwide.'